<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Tob Induc Dis</journal-id><journal-title>Tobacco Induced Diseases</journal-title><issn pub-type="ppub">1617-9625</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19570289</article-id><article-id pub-id-type="pmc">2643412</article-id><article-id pub-id-type="publisher-id">1617-9625-3-6</article-id><article-id pub-id-type="doi">10.1186/1617-9625-3-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Letter to the Editor</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Zavras</surname><given-names>A</given-names></name></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Falagas</surname><given-names>M</given-names></name></contrib></contrib-group><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>15</day><month>12</month><year>2005</year></pub-date><volume>3</volume><issue>1</issue><fpage>6</fpage><lpage>6</lpage><ext-link ext-link-type="uri" xlink:href="http://www.tobaccoinduceddiseases.com/content/3/1/6"/><permissions><copyright-statement>Copyright &#x000a9; 2005 BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>               Zavras               A            </dc:author><dc:title>            Letter to the Editor         </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>Tobacco Induced Diseases 3(1): 6-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1617-9625(2005)3:1&#x0003c;6&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1617-9625</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions></article-meta></front><body><sec><title/><p>Chair of Scientific Committee:</p><p>Dr. Athanasios I. Zavras, Harvard University &#x02013; ISPTID President</p><p>Dr. Matthew Falagas, Tufts Univ. &#x00026; Dunant Hospital</p><p>Scientific Committee Members:</p><p>Dr. Cynthia Boschi, World Health Organization</p><p>Dr. Carolyn Dresler, International Agency for Research on Cancer, WHO</p><p>Prof. Anthony Hedley, University of Hong Kong School of Medicine</p><p>Asst. Prof. Taru Kinnunen Mustonen, Harvard University School of Dentistry</p><p>Prof. Steve Sussman, Univ. of California San Francisco</p><p>Prof. David Scott, Univ. of Louisville School of Dental Medicine</p><p>Dr. Alexandra Shields, Georgetown University Institute for Health Policy</p><p>Organizing Committee Members:</p><p>Prof. Konstantinos Alexandridis, Univ. of Athens School of Dental Medicine</p><p>Asst. Prof. Vassillis Gorgoulis, Univ. of Athens School of Medicine</p><p>Dr. Argyris Michalopoulos, Intensive Care Unit, Dunant Hospital</p><p>Dr. Katerina Katsampe, Deputy Mayor of Athens</p><p>Prof. John Kyriopoulos, National School of Public Health</p><p>Mr. Kyriakos Souliotis, Onasion Cardiothoracic Surgery Hospital</p><p>Mr. Dimitrios Zavras, National School of Public Health</p><p>Dear Delegates</p><p>It is a great honor to host the 4th annual meeting of the International Society for the Prevention of Tobacco Induced Diseases in Athens, Greece. As the birthplace of democracy, Athens seems the ideal place for debate. And the subject, quantifying tobacco's impact, seems most suitable for scientific exchange.</p><p>Tobacco use is the single most important preventable risk factor for a number of debilitating diseases around the world. ISPTID global; membership is dedicated to the prevention of tobacco induced diseases. Some of the primary aims of the annual ISPTID conference are a) to disseminate important, state-of-the-science information about the biologic effects and the public health impact of tobacco use, b) to present updated data about the clinical signs and symptoms of tobacco induced disease and the various methods of smoking control and prevention, c) to create and facilitate research networks, and d) to educate healthcare professionals in tobacco control.</p><p>Financial interests, trade issues and taxation have allowed tobacco's spread for decades. The international community has recently agreed on a number of measures to curb tobacco use by adopting the first ever public health treaty, the Framework Convention of Tobacco Control (FCTC). The first indications of FCTC success around the world will be presented at the conference.</p><p>Apart from their strong international presentations, ISPTID conferences attempt to contribute to the promotion of tobacco control locally. Given the high prevalence of smoking in Greece, the Society will address the local media and will host a workshop for healthcare professionals on how to design and implement tobacco cessation programs in their prospective clinical settings.</p><p>We hope you enjoy the meeting.</p><p>For better health,</p><p>Athanasios I. Zavras, DMD, MS, DrMsc</p><p>ISPTID President</p><p>Matthew Falagas, MD, MPH</p><p>Chair of the Scientific Committee</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p>Please see additional file 1</p></caption><media xlink:href="1617-9625-3-6-S1.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body></article>